Skip to main content
. 2023 Feb 10;13:1099384. doi: 10.3389/fonc.2023.1099384

Table 1.

Patient and tumor characteristics.

Clinical feature All cases Baseline NLR P value
<2.21 ≧2.21
No.(%) No.(%)
Patient number 124 75 (60.5) 49 (39.5)
Age (means ± SD) 49.8 ± 12.9 47.0 ± 14.8 0.2694
Sex 0.2689
 Male 55 30 (54.5) 25 (45.5)
 Female 69 45 (65.2) 24 (34.8)
NF2 0.1104
 + 11 4 (36.4) 7 (63.6)
 - 113 71 (62.8) 49 (37.2)
Tumor status >0.9999
 primary 109 66 (60.6) 43 (39.4)
 recurrent 15 9 (60.0) 6 (40.0)
Tumor origin 0.2212
 CN 8 91 52 (57.1) 39 (42.8)
 non CN 8 33 23 (69.7) 10 (30.3)
Neurological symptoms 0.5629
 + 110 65 (59.1) 45 (40.9)
 - 14 10 (71.4) 4 (28.6)
Tumor size (mm) 24.8 ± 13.0 29.1 ± 12.0 0.0713
Brain compression 0.3416
 + 79 45 (57.0) 34 (43.0)
 - 45 30 (66.7) 15 (33.3)
Tumor cyst 0.3610
 + 59 33 (55.9) 26 (44.1)
 - 65 42 (64.6) 23 (35.4)
 Removal rate 0.0228
 GTR 46 34 (73.9) 12 (26.1)
 non-GTR 78 41 (52.6) 37 (47.4)

NLR, neutrophil-to-lymphocyte ratio; SD, standard deviation; NF2, neurofibromatosis type 2; CN, cranial nerve; GTR, gross total resection.

Factors which made statistically significant differences are shown in bold.